381 related articles for article (PubMed ID: 10048679)
1. Etiology and treatment of community-acquired pneumonia in ambulatory children.
Wubbel L; Muniz L; Ahmed A; Trujillo M; Carubelli C; McCoig C; Abramo T; Leinonen M; McCracken GH
Pediatr Infect Dis J; 1999 Feb; 18(2):98-104. PubMed ID: 10048679
[TBL] [Abstract][Full Text] [Related]
2. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Harris JA; Kolokathis A; Campbell M; Cassell GH; Hammerschlag MR
Pediatr Infect Dis J; 1998 Oct; 17(10):865-71. PubMed ID: 9802626
[TBL] [Abstract][Full Text] [Related]
4. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
5. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.
Gendrel D; Raymond J; Moulin F; Iniguez JL; Ravilly S; Habib F; Lebon P; Kalifa G
Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):388-91. PubMed ID: 9228482
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
7. Rapid optimization of antimicrobial chemotherapy given to pediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture.
Nakayama E; Hasegawa K; Morozumi M; Kobayashi R; Chiba N; Iitsuka T; Tajima T; Sunakawa K; Ubukata K
J Infect Chemother; 2007 Oct; 13(5):305-13. PubMed ID: 17982719
[TBL] [Abstract][Full Text] [Related]
8. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Gillies MB; Chang AB
Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
Langley JM; Halperin SA; Boucher FD; Smith B;
Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
[TBL] [Abstract][Full Text] [Related]
10. Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.
Gaillat J; Bru JP; Sedallian A
Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):639-44. PubMed ID: 7813493
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.
Michelow IC; Olsen K; Lozano J; Rollins NK; Duffy LB; Ziegler T; Kauppila J; Leinonen M; McCracken GH
Pediatrics; 2004 Apr; 113(4):701-7. PubMed ID: 15060215
[TBL] [Abstract][Full Text] [Related]
12. Community-acquired pneumonia in infants and children.
Ostapchuk M; Roberts DM; Haddy R
Am Fam Physician; 2004 Sep; 70(5):899-908. PubMed ID: 15368729
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Gardiner SJ; Gavranich JB; Chang AB
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754
[TBL] [Abstract][Full Text] [Related]
14. Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin.
Nascimento-Carvalho CM; Xavier-Souza G; Vilas-Boas AL; Fontoura MH; Barral A; Puolakkainen M; Ruuskanen O;
J Antimicrob Chemother; 2017 Aug; 72(8):2378-2384. PubMed ID: 28475737
[TBL] [Abstract][Full Text] [Related]
15. Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.
Korppi M
Paediatr Drugs; 2003; 5(12):821-32. PubMed ID: 14658923
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
17. Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Ghaffar F; Muniz LS; Katz K; Reynolds J; Smith JL; Davis P; Friedland IR; McCracken GH
Clin Infect Dis; 2000 Oct; 31(4):875-80. PubMed ID: 11049764
[TBL] [Abstract][Full Text] [Related]
18. Childhood community-acquired pneumonia.
Ruuskanen O; Mertsola J
Semin Respir Infect; 1999 Jun; 14(2):163-72. PubMed ID: 10391410
[TBL] [Abstract][Full Text] [Related]
19. Atypical and Typical Bacteria in Children with Community Acquired Pneumonia.
Jama-Kmiecik A; Frej-Mądrzak M; Sarowska J; Teryks-Wołyniec D; Skiba A; Choroszy-Król I
Adv Exp Med Biol; 2019; 1160():65-71. PubMed ID: 31016635
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course.
Marrie TJ; Peeling RW; Fine MJ; Singer DE; Coley CM; Kapoor WN
Am J Med; 1996 Nov; 101(5):508-15. PubMed ID: 8948274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
